Exchange, Financial Services, Industry, Latvia, Medicine
International Internet Magazine. Baltic States news & analytics
Thursday, 21.11.2024, 13:40
Grindex shareholders decide to delist the company
BC, Riga , 12.11.2020.
Print version
Print versionShareholders of Grindex pharmaceutical company at an extraordinary shareholders meeting today made a decision to delist the company from the regulated market, the company said in a statement to the Nasdaq Riga stock exchange.
 |
|---|
The decision was made with the required majority of votes.
The total number of shares and voting shares in the company is 9,585,000.
As reported, Grindex turned over EUR 94.517 million in the first half of 2020, which is an increase of 37% against the same period a year ago, while the group's profit grew 68.4% y-o-y to EUR 12.867 mln.
Grindex belongs to the Lipmans family, whose Liplat Holding owns 94.16% of the pharmaceutical group's shares. Grindex is quoted on the Main List of Nasdaq Riga stock exchange.
Other articles:
- 28.01.2022 BONO aims at a billion!
- 25.01.2021 Как банкиры 90-х делили «золотую милю» в Юрмале
- 30.12.2020 Накануне 25-летия Балтийский курс/The Baltic Course уходит с рынка деловых СМИ
- 30.12.2020 On the verge of its 25th anniversary, The Baltic Course leaves business media market
- 30.12.2020 Business Education Plus предлагает анонсы бизнес-обучений в январе-феврале 2021 года
- 30.12.2020 Hotels showing strong interest in providing self-isolation service
- 30.12.2020 EU to buy additional 100 mln doses of coronavirus vaccine
- 30.12.2020 ЕС закупит 100 млн. дополнительных доз вакцины Biontech и Pfizer
- 29.12.2020 В Rietumu и в этот раз создали особые праздничные открытки и календари 2021
- 29.12.2020 Latvia to impose curfew, state of emergency to be extended until February 7
«The Baltic Course» Is Sold and Stays in Business!
